First, virologic surveillance reports a low percentage of respiratory specimens testing positive for influenza in clinical laboratories (0.3%) during week 42. Few specimens have tested positive in public health labs recently.
Outpatient ILI surveillance indicates that 1.2% of healthcare visits were for ILI during week 42, which is below the national baseline of 2.6%. One jurisdiction experienced low activity, while the majority experienced minimal activity.
Hospitalization rates and P&I mortality rates have not been updated in the recent report. However, during the previous report, 7.6% of deaths were attributed to pneumonia, influenza, or COVID-19, which was above the epidemic threshold.
No influenza-associated pediatric deaths have been reported during the current season. Two deaths occurred during the 2019-2020 season.
Virus characterization data will be updated weekly later in the season when sufficient specimens have been tested.
CDC emphasizes the importance of annual flu vaccination and the availability of antiviral drugs for treating flu illness.